Anti-inflammatory activity possessing bio-compounds were identified from Kalanchoe pinnata methanolic leaf extract using Gas chromatography-mass spectrometry (GC-MS) analysis and their anti-inflammatory potential was checked using inhibition of albumin denaturation assay, anti-proteinase activity assay, and heat and hypotonicity induced hemolysis assay. GC-MS analysis revealed the presence of aldehydes, ketones, carboxylic acid in the crude. Antioxidant activity analysis using 2, 2-diphenyl-1-picrylhydrazyl (DPPH) assay revealed the half maximal inhibitory concentration (IC 50 ) value of methanol crude leaf extract as 100 μg/mL. The biocompatibility of the methanol extract was determined using 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay. The anti-inflammatory property of identified bio-compounds was also validated using a computational approach. Drug likelihood properties of phyto-compounds were analyzed by predicting the absorption, distribution, metabolism, and excretion (ADMET) score and the bioactivity score. Six chemical compounds with excellent drug relevant properties and availability were selected for a molecular docking study versus a common inflammatory molecular target COX-2 protein. The present study showed that anti-inflammatory properties of phyto-compounds from methanol crude leaf extract of Kalanchoe pinnata can be exploited for novel drug design to treat inflammatory disorders.
No takes yet. Share an insight, caveat, or question.
Agarwal et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: